InsidersTradesSigma
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
5
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Kariv Tomer. Officer active across 3 companies, notably Eloxx Pharmaceuticals, Inc.. Cumulatively, 6 disclosures have been recorded. Breakdown: 5 buys · 0 sell. Total volume traded: €2.9m. Activity tracked since 13 May 2021. The latest transaction was disclosed on 29 November 2022 (X). Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
3,539 shares@ US$0.0001100.0% of flowCommon StockSEC:0001209191-22-059051:0
1,280,624 shares@ US$1.3550.0% of flowCommon StockSEC:0001104659-21-067333:0
Ideal exit: 7 Feb 2022 (T+270)
1,280,624 shares@ US$1.3550.0% of flowCommon StockSEC:0001104659-21-067333
Ideal exit: 7 Feb 2022 (T+270)
707,868 sharesCommon StockSEC:0000914190-16-000516:0
Ideal exit: 8 Oct 2016 (T+270)
533,208 sharesCommon StockSEC:0000914190-16-000516:1
Ideal exit: 8 Oct 2016 (T+270)
206,986 sharesCommon StockSEC:0000914190-16-000516:2
Ideal exit: 8 Oct 2016 (T+270)
6 of 6 declarations
